Laboratory-grown blood has been transfused into a human being in a world's first clinical trial.
The manufactured blood cells were grown from stem cells from donors. Around 5-10 mls, or about one to two teaspoonfuls of red cells were then transfused into volunteers in the randomized controlled clinical trial.
The RESTORE trial is a joint research initiative by NHS Blood and Transplant (NHSBT) and the University of Bristol, working with the University of Cambridge, Guy's and St Thomas' NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Cambridge Clinical Research Facility, and Cambridge University Hospitals NHS Foundation Trust.
For comments and feedback contact: editorial@rttnews.com
Health News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.